Donovan Joanne M. 4
4 · Edgewise Therapeutics, Inc. · Filed May 7, 2025
Insider Transaction Report
Form 4
Transactions
- Exercise/Conversion
Common Stock
2025-05-01+10,417→ 26,775 total - Exercise/Conversion
Restricted Stock Units
2025-05-01−10,417→ 0 totalExercise: $0.00From: 2025-05-01Exp: 2032-05-01→ Common Stock (10,417 underlying) - Sale
Common Stock
2025-05-02$16.45/sh−5,187$85,348→ 21,588 total
Footnotes (2)
- [F1]Represents the number of shares sold to cover the statutory tax withholding obligations in connection with the vesting of Restricted Stock Units (RSUs). This sale satisfies the minimum statutory tax withholding obligations to be funded by a "sell-to-cover" transaction and does not represent a discretionary sale by the Reporting Person
- [F2]The price reported in column 4 is an average price. These shares were sold in multiple transactions at prices ranging from $16.07 to $16.84, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.